EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine

Mitsuyoshi Yoshimoto iD, Takuya Hayakawa, Masayuki Yamaguchi iD, Sadaaki Kimura, Hirofumi Fujii

PLOS ONE · 24.09.2024 · 19 (9) · e0310984

DOI: 10.1371/journal.pone.0310984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 24.09.2024. Verfasst von Mitsuyoshi Yoshimoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan. Hauptthemen laut MEDLINE: Liposomes, Pancreatic Neoplasms, Integrin alphaVbeta3, Deferoxamine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, the Foundation for the Promotion of Cancer Research in Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnetic resonance (MR) imaging is a powerful imaging modality for obtaining anatomical information with high spatial and temporal resolution. In the drug delivery system (DDS) framework, nanoparticles such as liposomes are potential candidates for MR imaging. We validated that RGD peptides are possible targeting molecules for pancreatic cancer with α v β 3 integrin expression. This study aimed to evaluate RGD-modified liposomes loaded with ferrioxamine B for pancreatic cancer imaging. We synthesized four types of RGD-modified liposomes encapsulated with ferrioxamine B (SH-, H-, M-, and L-RGD-liposomes). The binding affinity of RGD-modified liposomes was evaluated in a competitive inhibition study using 125 I-echistatin. To investigate the pharmacokinetics of RGD-modified liposomes, a biodistribution study using RGD-liposomes labeled with 111 In was carried out in a human pancreatic cancer PANC-1 xenograft mouse model. Finally, MR was performed using ferrioxamine-B-loaded liposomes. RGD-liposomes inhibited the binding of 125 I-echistatin to RGD. The biodistribution study revealed that 111 In-RGD-liposomes accumulated significantly in the liver and spleen. Among the 111 In-RGD-liposomes, 111 In-H-RGD-liposomes showed the highest tumor-to-normal tissue ratio. In the MR study, H-RGD-liposomes loaded with ferrioxamine B showed higher tumor-to-muscle signal ratios than RKG-liposomes loaded with ferrioxamine B (control). We successfully synthesized RGD-liposomes that can target α v β 3 integrin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesPancreatic NeoplasmsIntegrin alphaVbeta3DeferoxamineMagnetic Resonance ImagingOligopeptidesAnimalsMiceHumansCell Line, TumorTissue DistributionMice, NudeDisease Models, Animal

Substanzen

LiposomesIntegrin alphaVbeta3Deferoxaminearginyl-glycyl-aspartic acidOligopeptides

Autor:innen und Institutionen

  • Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan.

ORCID-Profile: Mitsuyoshi Yoshimoto, Masayuki Yamaguchi

Förderung

  • Japan Society for the Promotion of Science
  • the Foundation for the Promotion of Cancer Research in Japan

Zitieren

APA

Yoshimoto, M., Hayakawa, T., Yamaguchi, M., Kimura, S., & Fujii, H. (2024). αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine. PLOS ONE, 19(9), e0310984. https://doi.org/10.1371/journal.pone.0310984

Vancouver

Yoshimoto M, Hayakawa T, Yamaguchi M, Kimura S, Fujii H. αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine. PLOS ONE. 2024;19(9):e0310984. doi:10.1371/journal.pone.0310984

BibTeX
@article{Yoshimoto2024,
  author = {Yoshimoto, Mitsuyoshi and Hayakawa, Takuya and Yamaguchi, Masayuki and Kimura, Sadaaki and Fujii, Hirofumi},
  title = {αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0310984},
  doi = {10.1371/journal.pone.0310984}
}
Kostenlos starten →